Bosulif 100 mg (Bosutinib (Bosutinib Monohydrate) TABLET) 100 MG

Bosulif 100 mg tablets contain bosutinib monohydrate, a medication used to manage certain types of cancer. This oral treatment is designed for targeted therapy, offering a precise approach to cancer management.

Strength

100 MG

Pack Size

28/120

Manufacturer / TM Owner

PFIZER CANADA ULC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Bosulif 100 mg tablets are primarily used in the treatment of specific types of cancer. Bosutinib, the active ingredient, is a tyrosine kinase inhibitor that targets cancer cells. Patients often wonder, 'What is Bosulif used for?' This medication is typically prescribed for conditions like chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). It works by interfering with the growth and spread of cancer cells.

Side Effects

Common effects of Bosulif 100 mg tablets may include nausea, diarrhea, and fatigue. Some users also report skin rashes or changes in liver function. These effects can vary widely among individuals, and it's important to monitor any unusual symptoms while taking this medication.

Precautions & Warnings

Bosulif 100 mg tablets should be handled with care. Store them at room temperature, away from moisture and heat. Always follow the prescribed dosage and administration instructions provided by your healthcare professional. Avoid breaking or crushing the tablets unless directed to do so.

Avoid Interactions

Bosulif 100 mg tablets may interact with certain medications, including those that affect liver enzymes like CYP3A. It's important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol and other substances may also interact with bosutinib, so consult your healthcare provider for personalized advice.

Frequently Asked Questions

Bosulif is used in the treatment of certain types of cancer, such as chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).

Bosulif 100 mg tablets are taken orally, typically with food. Follow the dosage and administration instructions provided by your healthcare professional.

Common side effects may include nausea, diarrhea, fatigue, and skin rashes. Monitor for any unusual symptoms and consult your healthcare provider if they persist or worsen.

It's important to consult your healthcare provider about alcohol consumption while taking Bosulif, as it may interact with the medication.

Store Bosulif tablets at room temperature, away from moisture and heat. Keep them in their original packaging until ready to use.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.